These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36372921)

  • 21. Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies.
    Liu P; Zhu X; Wu W; Ludwig R; Song H; Li R; Zhou J; Tao L; Leone AM
    Rapid Commun Mass Spectrom; 2019 Jan; 33(1):31-40. PubMed ID: 30286260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
    Jakes C; Millán-Martín S; Carillo S; Scheffler K; Zaborowska I; Bones J
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1998-2012. PubMed ID: 33513021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-laboratory study of an optimised peptide mapping workflow using automated trypsin digestion for monitoring monoclonal antibody product quality attributes.
    Millán-Martín S; Jakes C; Carillo S; Buchanan T; Guender M; Kristensen DB; Sloth TM; Ørgaard M; Cook K; Bones J
    Anal Bioanal Chem; 2020 Oct; 412(25):6833-6848. PubMed ID: 32710279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-Attribute Method (MAM): An Emerging Analytical Workflow for Biopharmaceutical Characterization, Batch Release and cGMP Purity Testing at the Peptide and Intact Protein Level.
    Millán-Martín S; Jakes C; Carillo S; Gallagher L; Scheffler K; Broster K; Bones J
    Crit Rev Anal Chem; 2023 Jul; ():1-18. PubMed ID: 37490277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancing Mass Spectrometry Technology in cGMP Environments.
    Ren D
    Trends Biotechnol; 2020 Oct; 38(10):1051-1053. PubMed ID: 32718778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Method Development and Qualification of pH-Based CEX UPLC Method for Monoclonal Antibodies.
    Bhatt M; Alok A; Kulkarni BB
    BioTech (Basel); 2022 Jun; 11(2):. PubMed ID: 35822792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs.
    Song YE; Dubois H; Hoffmann M; D Eri S; Fromentin Y; Wiesner J; Pfenninger A; Clavier S; Pieper A; Duhau L; Roth U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122540. PubMed ID: 33545564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-Attribute Monitoring of Complex Erythropoetin Beta Glycosylation by GluC Liquid Chromatography-Mass Spectrometry Peptide Mapping.
    Buettner A; Maier M; Bonnington L; Bulau P; Reusch D
    Anal Chem; 2020 Jun; 92(11):7574-7580. PubMed ID: 32426963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Mass Accuracy and Precision for Multi-Attribute Methods Using a New Internally Calibrated High Resolution Orbitrap Mass Detector.
    Dawdy AW; Trujillo EA; Liu Z; Crone C; Kraegenbring J; Scheffler K
    Anal Chem; 2024 Apr; 96(17):6528-6533. PubMed ID: 38626116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully automated peptide mapping multi-attribute method by liquid chromatography-mass spectrometry with robotic liquid handling system.
    Qian C; Niu B; Jimenez RB; Wang J; Albarghouthi M
    J Pharm Biomed Anal; 2021 May; 198():113988. PubMed ID: 33676166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF.
    Can NÖ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvements on sample preparation and peptide separation for reduced peptide mapping based multi-attribute method analysis of therapeutic monoclonal antibodies using lysyl endopeptidase digestion.
    Li X; Rawal B; Rivera S; Letarte S; Richardson DD
    J Chromatogr A; 2022 Jul; 1675():463161. PubMed ID: 35635865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring multiple quality attributes of a complex Fc-fusion protein during cell culture production processes by mD-LC-MS peptide mapping.
    Camperi J; Dahotre S; Guillarme D; Stella C
    Talanta; 2022 Aug; 246():123519. PubMed ID: 35525056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive investigation of a structural variant in a bi-specific, N-and C-terminal Fc-fusion molecule, and its monitoring with LC-MS based method.
    Datola A; Satwekar A; Barron N; DeRosa S; Tomascak B; Dawson J; Palmese A; Rossi M
    Biotechnol Bioeng; 2023 Feb; 120(2):465-481. PubMed ID: 36333865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Gervais A; Dirksen EHC; Pohl T; Bechtold-Peters K; Burkitt W; D'Alessio V; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Oct; 191():57-67. PubMed ID: 37582411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring modifications in biopharmaceuticals: Toolbox for a generic and robust high-throughput quantification method.
    Bauer LG; Hoelterhoff S; Graf T; Bell C; Bathke A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1148():122134. PubMed ID: 32422530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Pohl T; Gervais A; Dirksen EHC; D'Alessio V; Bechtold-Peters K; Burkitt W; Cao L; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Jul; 188():231-242. PubMed ID: 37146738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry-based multi-attribute method for mutation analysis in the early development of therapeutic proteins.
    Liu T; Li Y; Xu J; Guo Q; Zhu L; Fu T; Li J; Zhang D; Qian W; Zhou X; Guo H; Hou S
    J Pharm Biomed Anal; 2022 Oct; 220():115018. PubMed ID: 36030755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics.
    Liu Y; Zhang C; Chen J; Fernandez J; Vellala P; Kulkarni TA; Aguilar I; Ritz D; Lan K; Patel P; Liu A
    J Pharm Sci; 2022 Feb; 111(2):358-367. PubMed ID: 34534574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of leukotriene B(4) in human sputum as a biomarker using UPLC-MS/MS.
    Jian W; Edom RW; Xue X; Huang MQ; Fourie A; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():59-65. PubMed ID: 23831697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.